TTK and cancer: Further functional studies of the compounds described in this work using an experimental approach will be carried out against a panel of cancer cells of diverse tissue origin, which should pave the way to identifying lead chemotypes, and, ultimately, to developing more effective therapeutics for the treatment of cancer and possibly other malignancies associated with Mps1 overexpression, defects in chromosome segregation, cell division, and cell proliferation.